Finance

Lists
HESTERBIO:NSE
Hester Biosciences Ltd
₹2,347.40
+0.98%
(+22.80) 1D
Nov 18, 1:01:09 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for HESTERBIO...
Open
₹2,320.00
High
₹2,375.00
Low
₹2,300.10
Mkt. cap
19.97B
Avg. vol.
4.67K
Volume
1.15K
Dividend
0.47%
Quarterly dividend
₹2.75
Ex-dividend date
Jul 14, 2026
P/E ratio
14.16
52-wk high
₹2,683.60
52-wk low
₹1,239.30
EPS
₹165.77
Shares outstanding
8.51M
No. of employees
483
Open
₹2,320.00
High
₹2,375.00
Low
₹2,300.10
Mkt. cap
19.97B
Avg. vol.
4.67K
Volume
1.15K
Dividend
0.47%
Quarterly dividend
₹2.75
Ex-dividend date
Jul 14, 2026
P/E ratio
14.16
52-wk high
₹2,683.60
52-wk low
₹1,239.30
EPS
₹165.77
Shares outstanding
8.51M
No. of employees
483
News stories
From web sources and news partners
ING Sprinters
ING Sprinters
·
12 hours ago
De AEX Index breekt steun
ZeelandNet, startpagina van Zeeland
ZeelandNet, startpagina van Zeeland
·
12 hours ago
AEX-index lager, chipbedrijven dalen in aanloop cijfers Nvidia
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees483
Founded1983
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
774.15M
1.02B
772.44M
979.12M
Cost of goods sold
207.28M
251.52M
170.79M
218.32M
Cost of revenue
207.28M
251.52M
170.79M
218.32M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155.18M
264.13M
148.84M
153.43M
Operating expense
433.25M
465.39M
444.32M
504.96M
Total operating expenses
640.53M
716.91M
615.11M
723.28M
Operating income
133.62M
299.41M
157.33M
255.84M
Other non operating income
6.69M
-133.21M
16.43M
15.32M
EBT including unusual items
135.24M
250.89M
1.02B
264.54M
EBT excluding unusual items
135.24M
203.96M
163.33M
260.35M
Income tax expense
42.14M
85.42M
49.50M
58.23M
Effective tax rate
31.16%
34.05%
4.87%
22.01%
Other operating expenses
233.76M
58.89M
225.04M
280.76M
Net income
87.65M
159.83M
969.81M
203.64M
Net profit margin
11.32%
15.73%
125.55%
20.80%
Earnings per share
-
-
-
-
Interest and investment income
-
15.79M
-
-
Interest expense
-18.22M
-15.77M
-30.80M
-29.85M
Net interest expenses
-18.22M
20.00K
-30.80M
-29.85M
Depreciation and amortization charges
44.31M
59.14M
70.44M
70.77M
EBITDA
174.66M
330.34M
188.26M
326.44M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps